4//SEC Filing
Ribeiro Ramiro 4
Accession 0001562180-24-002119
CIK 0001314102other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:40 PM ET
Size
5.8 KB
Accession
0001562180-24-002119
Insider Transaction Report
Form 4
Ribeiro Ramiro
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-03-01+125,000→ 125,000 totalExercise: $28.00Exp: 2034-03-01→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The option to purchase will vest and become exercisable as follows: 25% at March 1st, 2025 and the remainder ratably, on a monthly basis, over the remaining three years.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0002013623
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:40 PM ET
- Size
- 5.8 KB